Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/148049
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGershman, Mark D.-
dc.contributor.authorStaples, J.Erin-
dc.contributor.authorBentsi-Enchill, Adwoa D.-
dc.contributor.authorBreugelmans, J.Gabrielle-
dc.contributor.authorBrito, Glacus S.-
dc.contributor.authorBastos Camacho, Luiz A.-
dc.contributor.authorCottin, Pascale-
dc.contributor.authorDomingo, Cristina-
dc.contributor.authorDurbin, Anna-
dc.contributor.authorGascon, Joaquim-
dc.contributor.authorGuenaneche, Fouzia-
dc.contributor.authorHayes, Edward B.-
dc.contributor.authorJelenik, Zsuzsanna-
dc.contributor.authorKhromava, Alena-
dc.contributor.authorMenezes Martins, Reinaldo de-
dc.contributor.authorMasana Wilson, Mario-
dc.contributor.authorMassy, Nathalie-
dc.contributor.authorNasidi, Abdulsalami-
dc.contributor.authorNiedrig, Matthias-
dc.contributor.authorSherwat, Adam-
dc.contributor.authorTsai, Theodore-
dc.contributor.authorVilella i Morató, Anna-
dc.contributor.authorWilson, Mary Elisabeth-
dc.contributor.authorKohl, Katrin S.-
dc.contributor.authorThe Brighton Collaboration Viscerotropic Disease Working Group-
dc.date.accessioned2020-01-16T15:52:54Z-
dc.date.available2020-01-16T15:52:54Z-
dc.date.issued2012-07-13-
dc.identifier.issn0264-410X-
dc.identifier.urihttp://hdl.handle.net/2445/148049-
dc.description.abstractViscerotropic disease (VTD) is defined as acute multiple organ system dysfunction that occurs following vaccination. The severity of VTD ranges from relatively mild multisystem disease to severe multiple organ system failure and death. The term VTD was first used shortly after the initial published reports in 2001 of febrile multiple organ system failure following yellow fever (YF) vaccination. To date, VTD has been reported only in association with YF vaccine and has been thus referred to as YF vaccine-associated viscerotropic disease (YEL-AVD).-
dc.format.extent28 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.vaccine.2012.04.067-
dc.relation.ispartofVaccine, 2012, vol. 30, num. 33, p. 5038-5058-
dc.relation.urihttps://doi.org/10.1016/j.vaccine.2012.04.067-
dc.rights(c) Elsevier B.V., 2012-
dc.sourceArticles publicats en revistes (Medicina)-
dc.subject.classificationVacunació-
dc.subject.classificationEfectes secundaris dels medicaments-
dc.subject.otherVaccination-
dc.subject.otherDrug side effects-
dc.titleViscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec618829-
dc.date.updated2020-01-16T15:52:54Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid22561144-
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
618829.pdf1.02 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.